While mutations in the Protection of Telomeres 1 (POT1) gene are well‐established as factors in the development of melanoma and lung cancer, it has been suggested that POT1 testing could be beneficial for patients with familial cancer syndromes [54, 55, 56]. Here, POT1 is linked to lung carcinoma.